Ion Beam Applications (XBRU:IBAS) 3-Year EBITDA Growth Rate : -29.50% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Ion Beam Applications 3-Year EBITDA Growth Rate?

Ion Beam Applications's EBITDA per Share for the six months ended in Dec. 2023 was €0.93.

During the past 12 months, Ion Beam Applications's average EBITDA Per Share Growth Rate was 37.90% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -29.50% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ion Beam Applications was 77.30% per year. The lowest was -51.60% per year. And the median was -10.90% per year.

Competitive Comparison of Ion Beam Applications's 3-Year EBITDA Growth Rate

For the Medical Devices subindustry, Ion Beam Applications's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ion Beam Applications's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ion Beam Applications's 3-Year EBITDA Growth Rate falls into.

Ion Beam Applications 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Ion Beam Applications (XBRU:IBAS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Ion Beam Applications 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Ion Beam Applications's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ion Beam Applications (XBRU:IBAS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ion Beam Applications SA (XBRU:IBAS) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

IOBCF:USA 0GZK:UK IOB:Germany IBAB:Belgium

Address

Chemin du Cyclotron, 3, Louvain-La-Neuve, BEL, B-1348

Website

https://www.iba-worldwide.com

Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World, with REst-of-World sales generating the largest proportion of revenue.

Ion Beam Applications (XBRU:IBAS) Headlines

No Headlines